Finance

Results from Phase 1/2 Study of Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-™T) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to...

https://www.investing.com/news/press-releases/results-from-phase-12-study-of-kelunbiotechs-trop2-adc-sacituzumab-tirumotecan-sact-in-patients-with-unresectable-locally-advanced-or-metastatic-solid-tumors-refractory-to-standard-therapies-93CH-4089341 Investing.com

ACDC Stock Hits 52-Week High at $9.49 Amid Market Optimism

https://www.investing.com/news/company-news/acdc-stock-hits-52week-high-at-949-amid-market-optimism-93CH-4089319 Investing.com

Russia fines Apple for violating 'LGBT propaganda' law, TASS reports

https://www.investing.com/news/stock-market-news/russia-fines-apple-for-violating-lgbt-propaganda-law-tass-reports-4089290 Reuters

Novo Nordisk starts new CagriSema weightloss drug trial

https://www.investing.com/news/stock-market-news/novo-nordisk-starts-new-cagrisema-weightloss-drug-trial-4089275 Reuters

Latest articles

spot_imgspot_img